CurrentColorado Rocky Mountain Health PlansPolicy 2026T0400Z

Virtual Upper Gastrointestinal Endoscopy

Policy on the use of virtual upper GI endoscopy (3-D CT or 3-D MRI virtual gastroscopy/esophagography) to detect and evaluate upper GI lesions for UnitedHealthcare Commercial and Individual Exchange plans.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyVirtual Upper Gastrointestinal Endoscopy

Policy CodePolicy 2026T0400Z

Change TypeTemplate updatearchival of prior versions

Effective DateJan 1, 2026

Next Review Date

Key ActionVerify member-specific benefit plan and document plan terms before submitting virtual upper GI endoscopy for coverage.

SourceLink

POLICY UPDATE CHANGES

Created shared policy version to support application to Oxford plan membership and archived previous policy versions

no RCTsrandomized controlled trials available

98%detection rate (primary tumors)

89%T staging accuracy (MPR)

78%N staging accuracy (MPR)

386sample size (Kim et al.)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria — Virtual Upper GI Endoscopy

Not medically necessary

Covered when ALL of the following are met

Coverage Rationale: Virtual upper GI endoscopy using 3-D CT or 3-D MRI is unproven and not medically necessary for detecting and evaluating upper GI lesions due to insufficient evidence of efficacy.

Policy conclusion based on the body of evidence consisting primarily of observational studies, case reports, and technical reports; lack of randomized controlled trials and small study sizes cited.

Virtual upper gastrointestinal (GI) endoscopy using three-dimensional (3‑D) computed tomography or 3‑D magnetic resonance imaging is not covered as medically necessary for detecting and evaluating upper GI lesions. This procedure is considered unproven and not medically necessary due to insufficient evidence of efficacy.

The European Society of Gastrointestinal Endoscopy (ESGE) 2022 update advises that superficial GI lesions should be evaluated endoscopically by an experienced endoscopist using high‑definition white‑light and chromoendoscopy with validated classifications. ESGE does not recommend routine performance of EUS, CT, MRI, or PET‑CT before endoscopic resection (ER) (strong recommendation).

Rationale: The available evidence for virtual upper GI endoscopy is limited to observational studies, case reports, and technical feasibility reports, with no randomized controlled trials identified. Studies commonly have small sample sizes, single‑center designs, and lack standardized comparisons to conventional endoscopy; there is insufficient direct evidence that virtual techniques improve diagnostic accuracy in ways that change management or long‑term patient outcomes. Because of these evidence gaps, the procedure is considered unproven and not medically necessary for routine detection and evaluation of upper GI lesions.

Coding and Product Codes

Applicable Codes (reference only)CPT

76497	Unlisted computed tomography procedure (e.g., diagnostic, interventional).
76498	Unlisted magnetic resonance procedure (e.g., diagnostic, interventional).

FDA imaging device product codesmixed

JAK	FDA product code classification for certain imaging devices
LLZ	FDA product code classification for certain imaging devices
LNH	FDA product code classification for certain imaging devices

Provider Actions, Billing, and Verification

Denial Risk

Coverage Stance and Billing Risk

Virtual upper GI endoscopy using 3‑D CT or 3‑D MRI is considered investigational/unproven and not medically necessary. Claims for this procedure are subject to denial under Colorado Rocky Mountain Health Plans when billed as an alternative to conventional endoscopy for detection or evaluation of upper GI lesions.

Affected example procedure codes (reference only): 76497 (Unlisted CT procedure), 76498 (Unlisted MR procedure). Listing does not imply coverage.
Prior authorization: Check member-specific benefit plan; prior authorization requirements are not specified in this policy excerpt — verify per member plan.
Member-specific verification: Always confirm benefits and applicable federal/state mandates before applying this policy. The member specific benefit plan document governs in case of conflict.
Documentation: Maintain clinical documentation supporting use of the service; lack of evidence supporting clinical efficacy may result in claim denial.

Background — Procedure Description and Evidence Context

Background: Virtual upper GI endoscopy (also described as virtual gastroscopy or virtual esophagography) uses three‑dimensional CT or MRI image reconstruction to create endoscopy‑like views of the mucosal surfaces of the esophagus, stomach, and proximal duodenum. The technique relies on dedicated distention protocols (air or water) and image post‑processing to generate intraluminal perspectives without sedation or the ability to obtain tissue biopsy; it is proposed for evaluation of symptoms such as nausea, reflux, abdominal pain, weight loss, and for detection or staging of lesions including varices, ulcers, precancerous conditions, subepithelial masses, and gastric cancer.

Definitions

Virtual upper gastrointestinal endoscopy — definition

DefinitionNoninvasive imaging procedure using 3-D CT or MRI to create endoscopy-like views of upper GI tract surfaces; does not allow tissue biopsy and may require distention techniques (air or water).

Typical usesProposed to evaluate symptoms such as nausea, reflux, abdominal pain, unexplained weight loss, and to identify esophageal varices, inflammation, ulcers, precancerous conditions, and hernias.

Sedation and anesthesiaIndividuals usually do not require anesthesia or sedation because this is an imaging procedure.

LimitationsCannot perform biopsy during the procedure; may show less fine detail than standard endoscopy and involves CT radiation exposure when CT is used.

MDCT / virtual gastroscopy — definition and key findings

Term

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyVirtual Upper Gastrointestinal Endoscopy

Policy CodePolicy 2026T0400Z

Change TypeTemplate updatearchival of prior versions

Effective DateJan 1, 2026

Next Review Date

Key ActionVerify member-specific benefit plan and document plan terms before submitting virtual upper GI endoscopy for coverage.

SourceLink

On This Page

Billing Rule

Applicable Codes (reference only)

The following CPT codes are provided for reference only. Inclusion does not imply coverage or guarantee payment. Verify member benefits and any prior authorization requirements before billing.

CPT 76497 — Unlisted computed tomography procedure (e.g., diagnostic, interventional)
CPT 76498 — Unlisted magnetic resonance procedure (e.g., diagnostic, interventional)

Prior Authorization

Prior authorization requirements are not specified in this policy extract. Providers must check the member-specific benefit plan and any applicable plan tools (e.g., prior auth portals) to determine if authorization is required prior to performing or billing for this service.

Documentation Required

Plan & Member Verification Required

Before applying this policy, verify the member-specific benefit plan and applicable federal/state mandates. In the event of a conflict, the member-specific benefit plan governs. This policy is informational and does not replace the member’s benefit document.

MDCT / virtual gastroscopy

Technique detailsMDCT protocols in studies include acquisition of virtual gastroscopy (VG) images after air distention and contrast-enhanced dynamic transverse and multiplanar reconstruction (MPR) images after water distention.

Diagnostic performanceIn Chen et al. (2007), detection rates for primary gastric tumors were 91% (transverse), 96% (MPR), and 98% (combined MPR + virtual gastroscopy); overall T staging accuracy with MPR was 89%.

ER — endoscopic resection (context and guideline note)

DefinitionEndoscopic resection (ER) — an interventional endoscopic procedure to remove superficial gastrointestinal lesions.

Guideline recommendationESGE (2022) recommends evaluation of superficial GI lesions by an experienced endoscopist using high-definition white-light and chromoendoscopy; does not recommend routine EUS, CT, MRI, or PET-CT before ER (strong recommendation).

ImplicationCross-sectional imaging (including MDCT/virtual gastroscopy) is not routinely recommended before endoscopic resection according to ESGE guidance.